Glioblastoma (GB) stands out as the most prevalent and lethal form of brain cancer.
Although great efforts have been made by clinicians and researchers, no significant …

Glioblastoma (GBM) is one of the most lethal central nervous systems (CNS) tumours in
adults. As supplements to standard of care (SOC), various immunotherapies improve the …

Glioblastoma is an aggressive primary brain tumor that has seen few advances in treatments
for over 20 years. In response to this desperate clinical need, multiple immunotherapy …

Abstract Three-dimensional (3D) bioprinting is a novel technology that enables the creation
of 3D structures with bioinks, the biomaterials containing living cells. 3D bioprinted …

Bradykinin is a small active peptide and is considered an inflammatory mediator in several
pathological conditions. Bradykinin exerts its effects by coupling to its receptors, including …

Focused ultrasound (FUS) combined with intravascularly circulating microbubbles can
transiently increase the permeability of the blood-brain barrier (BBB) to enable targeted …

The 2021 World Health Organization Classification of Tumors of the Central Nervous System
reflected advances in understanding of the roles of oncohistones in gliomagenesis with the …

Despite substantial advances in cancer treatment, for patients with glioblastoma prognosis
remains bleak. The emerging field of cancer neuroscience reveals intricate functional …

The protein disulfide isomerase A3 (PDIA3) is directly or indirectly involved in various
physiopathological processes and participates in cancer initiation, progression and …

Glioblastoma remains one of the most aggressive cancers of the brain, warranting new
methods for early diagnosis and more efficient treatment options. Circular RNAs (circRNAs) …